- $45.68bn
- $67.17bn
- $4.08bn
- 55
- 49
- 59
- 54
C2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,488 | 1,647 | 2,080 | 3,344 | 4,079 |
Cost of Revenue | |||||
Gross Profit | 1,400 | 1,542 | 1,947 | 3,117 | 3,762 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,076 | 1,317 | 1,752 | 2,535 | 3,183 |
Operating Profit | 412 | 330 | 329 | 809 | 896 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 444 | 411 | 392 | 918 | 929 |
Provision for Income Taxes | |||||
Net Income After Taxes | 437 | 397 | 361 | 872 | 877 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 436 | 395 | 359 | 869 | 872 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 436 | 395 | 359 | 869 | 872 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.41 | 1.38 | 1.42 | 1.32 | 1.36 |
Dividends per Share |